Anxiety and Related Sleep Disorders - United Kingdom

United Kingdom

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$253.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 1.19%, resulting in a market volume of US$265.60m by 2028.
In global comparison, most revenue will be generated in the United States (US$3,213.00m in 2024).
In relation to total population figures, per person revenues of US$61.63 are generated in 2024.

Key regions: China, United Kingdom, Germany, France, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Anxiety and Related Sleep Disorders market in United Kingdom is experiencing significant growth due to increasing customer preferences for natural remedies and alternative therapies, as well as the rising awareness and diagnosis of these conditions.

Customer preferences: Customers in the United Kingdom are increasingly seeking natural remedies and alternative therapies for anxiety and related sleep disorders. This shift in preference can be attributed to a growing awareness of the potential side effects and addictive nature of traditional pharmaceutical treatments. Additionally, customers are becoming more interested in holistic approaches to healthcare, focusing on overall well-being rather than simply treating symptoms. As a result, there has been a surge in demand for products and services that promote relaxation, stress reduction, and improved sleep quality.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in the United Kingdom is the growing popularity of herbal supplements and natural remedies. Customers are turning to herbal remedies such as chamomile, lavender, and valerian root, which are known for their calming and sleep-inducing properties. These natural alternatives are perceived as safer and gentler on the body, leading to increased sales and market growth.Another trend in the market is the rise of mindfulness-based therapies. Mindfulness techniques, such as meditation and yoga, have gained popularity as effective tools for managing anxiety and improving sleep. Customers are increasingly seeking out mindfulness programs and classes, as well as mindfulness-based apps and online resources. This trend is driven by the desire for non-pharmaceutical solutions and the growing recognition of the mind-body connection in mental health.

Local special circumstances: The United Kingdom has a well-established healthcare system that provides accessible mental health services to its population. This has contributed to the increased awareness and diagnosis of anxiety and related sleep disorders. The National Health Service (NHS) offers a range of treatments and therapies for these conditions, including cognitive-behavioral therapy (CBT) and medication. However, the demand for alternative and complementary therapies remains strong, as many customers prefer a more holistic approach to their mental health.

Underlying macroeconomic factors: The United Kingdom has a stable economy with a high standard of living, which allows customers to prioritize their mental well-being. As disposable incomes increase, individuals are more willing to invest in products and services that promote relaxation and better sleep. Additionally, the growing awareness and destigmatization of mental health issues in society have led to a greater willingness to seek help and explore different treatment options. These factors contribute to the overall growth of the Anxiety and Related Sleep Disorders market in the United Kingdom.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.